XIAMEN SINOPEG BIOTECH CO LTD
Overview
XIAMEN SINOPEG BIOTECH CO LTD is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering 2-arm PEG-MAL(LYS01)-40K; METHOXYPOLY (ETHYLENE GLYCOL) MALEIMIDE-20K; METHOXYPOLY (ETHYLENE GLYCOL) PROPIONALDEHYDE; METHOXYPOLY (ETHYLENE GLYCOL) SUCCINIMIDYL CARBONATE 5K; METHOXYPOLY (ETHYLENE GLYCOL) SUCCINIMIDYL SUCCINATE 5K; SEMAGLUTIDE SIDE CHAIN, TBUOSTE-GLU(AEEA-AEEA-OH)-OTBU.
API / Drug Master Files
XIAMEN SINOPEG BIOTECH CO LTD holds 7 active (7 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- STEMERY® SERUM REPLACEMENTActive2025-03-27
- METHOXYPOLY (ETHYLENE GLYCOL) MALEIMIDE-20KActive2022-07-07
- 2-arm PEG-MAL(LYS01)-40KActive2021-05-26
- SEMAGLUTIDE SIDE CHAIN, TBUOSTE-GLU(AEEA-AEEA-OH)-OTBUActive2021-04-10
- METHOXYPOLY (ETHYLENE GLYCOL) SUCCINIMIDYL SUCCINATE 5KActive2019-05-08
- METHOXYPOLY (ETHYLENE GLYCOL) SUCCINIMIDYL CARBONATE 5KActive2017-04-20
- METHOXYPOLY (ETHYLENE GLYCOL) PROPIONALDEHYDEActive2016-09-25
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to XIAMEN SINOPEG BIOTECH CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.